Provided by Tiger Trade Technology Pte. Ltd.

Global X Genomics & Biotechnology ETF

65.05
-1.7220-2.58%
Volume:15.48K
Turnover:1.00M
Market Cap:92.68M
PE:- -
High:66.06
Open:66.06
Low:64.03
Close:66.77
52wk High:66.88
52wk Low:36.00
Shares:1.42M
Float Shares:1.42M
Volume Ratio:1.00
T/O Rate:1.09%
Dividend:0.65
Dividend Rate:1.00%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Bonds, Cryptos, Moderna Play Havoc with Markets. 2 Reasons for More Chaos.

Dow Jones
·
Aug 21

Insight Guru Says Health Care Dominates Mid-Cap 52-Week Highs List, with 9 of 15 Names at Peaks

Reuters
·
Aug 21

Moderna’s Personalized MRNA Shot Could Reshape the Fight Against Skin Cancer — but It May Also Be Overhyped

Dow Jones
·
Aug 21

How Moderna’s Historic Short Squeeze Upended the AI Chip Trade

Dow Jones
·
Aug 21

Moderna : JP Morgan Raises Target Price to $77 from $40

THOMSON REUTERS
·
Aug 21

Top Illumina Executive Unloads Shares in Notable Insider Move

TIPRANKS
·
Aug 21

ETF Daily | MRAL Surges 31%; AGQ Gains 5%; UCO Rises 3%; MRNX Plunges 48%; Crypto-Leveraged Products Dominate

ETF Tracker
·
Aug 21

24H | Ross Stores Jumps Over 8% After Earnings; Strategy Rises Another 2%; Moderna Slips Another 2%

US Overnight
·
Aug 21

Review & Preview: the Market's Terrible, Horrible, no Good, Very Bad Day

Dow Jones
·
Aug 21

Overnight Market Wrap: US Stocks Slide as Long-Dated Treasury Yields Rebound; Moderna Tumbles 23.5%

Stock News
·
Aug 21

Stocks to Watch Thursday Recap: Strategy, Moderna, Walmart

Dow Jones
·
Aug 21

Thursday's Top 20 US Stock Transactions: Micron Rises 3.97% Following $10 Billion Research Lab Announcement

Deep News
·
Aug 21

Moderna Inc. Stock Slips 23.5%, Underperforms Peers

Dow Jones
·
Aug 21

Illumina SVP Jakob Wedel Christensen Sells 1,033 Shares Worth $197,040.16

Reuters
·
Aug 21

Twist Bioscience President and COO Patrick John Finn Disposes of 78,355 Common Shares Worth $9.28 Million

Reuters
·
Aug 21

Sector Update: Healthcare

MT Newswires Live
·
Aug 21

Moderna is up 350% Since Our Recommendation. Here's What to Do Next.

Dow Jones
·
Aug 21

Moderna’s RSV Vaccine Trial Reaches Completion, Setting Up a Key Catalyst for MRNA

TIPRANKS
·
Aug 21

Moderna falls -19.9%

TIPRANKS
·
Aug 21

After Day of Exuberance for Moderna's Stock, Investors Pull Back

Dow Jones
·
Aug 20